ArticleJournal of Cancer2016

Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma.

Jing Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.